In Talks With Drugmakers In India To Produce Experimental COVID-19 Drug Remdesivir: US Firm Gilead
Gilead Sciences, US Pharma major, on Wednesday, May 6, announced it was in discussion with some of the world's leading chemical and pharmaceutical companies including in India to manufacture remdesivir, an experimental COVID-19 drug. The discussion is taking place to produce remdesivir, Gilead's...
COVID-19: Clinical Trial Of Antiviral Drug Remdesivir Shows Patients Recover Faster
The Logical Indian Crew